Clinical Trial Update: A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma. [Phase 3]

View source ↗

Summary

This Phase 3 trial compares venetoclax plus dexamethasone versus pomalidomide plus dexamethasone in t(11;14)-positive relapsed or refractory multiple myeloma, d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Pomalyst (pomalidomide)
• Venclyxto (Venetoclax)

Snippet

Sponsor: AbbVie | Conditions: Multiple Myeloma | Phase 3 | Status: ACTIVE_NOT_RECRUITING